Evidence map›Paper›PMID 39137246›Full record

ArticleScience signaling2024

Phosphorylation patterns in the AT1R C-terminal tail specify distinct downstream signaling pathways.

Clarice Gareri, Conrad T Pfeiffer, Xue Jiang, Joao A Paulo, Steven P Gygi, Uyen Pham, Anand Chundi, Laura M Wingler, Dean P Staus, Tomasz Maciej Stepniewski and 5 more

Abstract read
In one paragraph

Article in Science signaling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Clarice GareriDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0002-4859-8780
Conrad T PfeifferDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Xue JiangDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0009-0008-1098-7204
Joao A PauloDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-4291-413X
Steven P GygiDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-7626-0034
Uyen PhamDepartment of Biochemistry, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0002-2038-6794
Anand ChundiDepartment of Biomedical Engineering, Duke University, Durham, NC 27710, USA.ORCID 0000-0001-8148-7479
Laura M WinglerDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0002-3688-5088
Dean P StausDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Tomasz Maciej StepniewskiResearch Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM)-Pompeu Fabra University (UPF), 08003 Barcelona, Spain.ORCID 0000-0002-6828-9192
Jana SelentResearch Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM)-Pompeu Fabra University (UPF), 08003 Barcelona, Spain.ORCID 0000-0002-1844-4449
Emilio Y LuceroDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0001-5056-7126
Alyssa GroganDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0002-1505-3311
Sudarshan RajagopalDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0002-3443-5040
Howard A RockmanDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0003-2921-1584

Funding

Regulation of Beta-Adrenergic Receptor Signaling by S-NitrosylationP01HL075443 · NHLBI · DUKE UNIVERSITY · PI STAMLER, JONATHAN S. · 2004 to 2019
$26.1M
MECHANISMS OF MALADAPTATION IN HEART FAILURER01HL056687 · NHLBI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI Howard A Rockman · 1996 to 2026
$12.3M
New Sample Multiplexing Technologies to Identify Chemical Probes and Illuminate Ubiquitin BiologyR01GM067945 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GYGI, STEVEN P · 2003 to 2024
$10.5M
MULTIDISCIPLINARY HEART &VASCULAR DISEASEST32HL007101 · NHLBI · DUKE UNIVERSITY · PI FREEDMAN, NEIL J. · 1985 to 2020
$9.8M
Biasing CXCR3 Signaling to Modulate the Inflammatory ResponseR01GM122798 · NIGMS · DUKE UNIVERSITY · PI RAJAGOPAL, SUDARSHAN · 2017 to 2025
$3.2M
Advancing Multiplexed Isobaric Tag-based Strategies for Proteome ProfilingR01GM132129 · NIGMS · HARVARD MEDICAL SCHOOL · PI PAULO, JOAO A · 2019 to 2023
$1.7M
NHLBI NIH HHS P01 HL075443NHLBI NIH HHS R01 HL056687NHLBI NIH HHS T32 HL007101NIGMS NIH HHS R01 GM067945NIGMS NIH HHS R01 GM122798NIGMS NIH HHS R01 GM132129
6 · The paper itself

Abstract

Different ligands stabilize specific conformations of the angiotensin II type 1 receptor (AT1R) that direct distinct signaling cascades mediated by heterotrimeric G proteins or β-arrestin. These different active conformations are thought to engage distinct intracellular transducers because of differential phosphorylation patterns in the receptor C-terminal tail (the "barcode" hypothesis). Here, we identified the AT1R barcodes for the endogenous agonist AngII, which stimulates both G protein activation and β-arrestin recruitment, and for a synthetic biased agonist that only stimulates β-arrestin recruitment. The endogenous and β-arrestin-biased agonists induced two different ensembles of phosphorylation sites along the C-terminal tail. The phosphorylation of eight serine and threonine residues in the proximal and middle portions of the tail was required for full β-arrestin functionality, whereas phosphorylation of the serine and threonine residues in the distal portion of the tail had little influence on β-arrestin function. Similarly, molecular dynamics simulations showed that the proximal and middle clusters of phosphorylated residues were critical for stable β-arrestin-receptor interactions. These findings demonstrate that ligands that stabilize different receptor conformations induce different phosphorylation clusters in the C-terminal tail as barcodes to evoke distinct receptor-transducer engagement, receptor trafficking, and signaling.

Indexed as

beta-ArrestinsReceptor, Angiotensin, Type 1Signal TransductionAngiotensin IIHEK293 CellsHumansMolecular Dynamics SimulationPhosphorylationAngiotensin IIbeta-ArrestinsReceptor, Angiotensin, Type 1

Identifiers

PMID39137246
PMCPMC11443182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.